Literature DB >> 32817261

Impact of body mass index on development of nontuberculous mycobacterial pulmonary disease.

Jin Hwa Song1, Bong Seong Kim2, Nakwon Kwak3, Kyungdo Han2, Jae-Joon Yim3.   

Abstract

The incidence and prevalence of nontuberculous mycobacterial pulmonary disease (NTM-PD) have been increasing worldwide. The risk of NTM-PD may be higher in undernourished populations. In this study, we tried to elucidate the impact of body mass index (BMI) and its change on development of NTM-PD.We performed a retrospective cohort study including South Koreans aged >40 years who underwent biennial National Health Insurance System (NHIS) health check-ups in both 2005 and 2009 or 2006 and 2010. We monitored eligible individuals from the study initiation date (NHIS health check-up date in 2009 or 2010) until the diagnosis of NTM-PD or until December 31, 2017. Enroled individuals were classified based on BMI at initiation date. By calculating hazard ratios, we compared NTM-PD incidence per 100 000 person-years by BMI group and by BMI change.A total of 5 670 229 individuals were included in the final analysis. Compared with the BMI <18.5 kg·m-2 group, the incidence of NTM-PD gradually decreased with increased BMI (adjusted hazard ratio 0.38, 95% confidence interval (CI) 0.35-0.42 for BMI 18.5-22.9; 0.17, 95% CI 0.15-0.19 for BMI 23-24.9; 0.1, 95% CI 0.09-0.11 for BMI 25-29.9; and 0.1, 95% CI 0.07-0.13 for BMI ≥30). A BMI decrease of ≥1 kg·m-2 over 4 years increased the incidence of NTM-PD (adjusted hazard ratio 1.08, 95% CI 1.01-1.16) whereas a BMI increase of ≥1 kg·m-2 decreased the incidence of NTM-PD (adjusted hazard ratio 0.77, 95% CI 0.71-0.83).In conclusion, BMI was inversely related to development of NTM-PD and weight loss increased the risk of NTM-PD. ©ERS 2021. For reproduction rights and permissions contact permissions@ersnet.org.

Entities:  

Year:  2021        PMID: 32817261     DOI: 10.1183/13993003.00454-2020

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  8 in total

1.  Pulmonary mycobacterial infection is associated with increased mortality in patients with acute respiratory distress syndrome.

Authors:  Jong Hwan Jeong; Manbong Heo; Sunmi Ju; Seung Jun Lee; Yu Ji Cho; Yi Yeong Jeong; Jong Deog Lee; Jung-Wan Yoo
Journal:  Medicine (Baltimore)       Date:  2021-08-20       Impact factor: 1.817

2.  Amikacin Liposomal Inhalation Suspension in the Treatment of Mycobacterium abscessus Lung Infection: A French Observational Experience.

Authors:  Raphael Chiron; Wouter Hoefsloot; Jakko Van Ingen; Hélène Marchandin; Laurent Kremer; Hélène Morisse-Pradier; Jeremy Charriot; Jean-Pierre Mallet; Jean-Louis Herrmann; Davide Caimmi; Johan Moreau; Yann Dumont; Sylvain Godreuil; Anne Bergeron; Margot Drevait; Elodie Bouzat-Rossigneux; Nicolas Terrail; Claire Andrejak; Nicolas Veziris; Dominique Grenet; Alexandre Coudrat; Emilie Catherinot
Journal:  Open Forum Infect Dis       Date:  2022-09-11       Impact factor: 4.423

3.  Osteoporosis in nontuberculous mycobacterial pulmonary disease: a cross-sectional study.

Authors:  Hiromu Tanaka; Takanori Asakura; Shoji Suzuki; Satoshi Okamori; Tatsuya Kusumoto; Takunori Ogawa; Shunsuke Uno; Atsuho Morita; Ho Lee; Ho Namkoong; Hirofumi Kamata; Yasunori Sato; Yoshifumi Uwamino; Tomoyasu Nishimura; Makoto Ishii; Koichi Fukunaga; Naoki Hasegawa
Journal:  BMC Pulm Med       Date:  2022-05-21       Impact factor: 3.320

Review 4.  Incidence of Nontuberculous Mycobacterial Pulmonary Infection, by Ethnic Group, Hawaii, USA, 2005-2019.

Authors:  Rebekah A Blakney; Emily E Ricotta; Timothy B Frankland; Stacey Honda; Adrian Zelazny; Katrin D Mayer-Barber; Samantha G Dean; Dean Follmann; Kenneth N Olivier; Yihe G Daida; D Rebecca Prevots
Journal:  Emerg Infect Dis       Date:  2022-08       Impact factor: 16.126

5.  Comorbidities of nontuberculous mycobacteria infection in Korean adults: results from the National Health Insurance Service-National Sample Cohort (NHIS-NSC) database.

Authors:  Seung Won Lee; Youngmok Park; Sol Kim; Eun Ki Chung; Young Ae Kang
Journal:  BMC Pulm Med       Date:  2022-07-23       Impact factor: 3.320

6.  Severity of underweight affects the development of nontuberculous mycobacterial pulmonary disease; a nationwide longitudinal study.

Authors:  Ji Young Kang; Kyungdo Han; Mee Kyoung Kim
Journal:  Sci Rep       Date:  2022-10-13       Impact factor: 4.996

7.  Factors affecting in-hospital mortality of non-tuberculous mycobacterial pulmonary disease.

Authors:  Goh Tanaka; Taisuke Jo; Hiroyuki Tamiya; Yukiyo Sakamoto; Wakae Hasegawa; Hiroki Matsui; Kiyohide Fushimi; Hideo Yasunaga; Takahide Nagase
Journal:  BMC Infect Dis       Date:  2021-07-20       Impact factor: 3.090

8.  The 6-minute walk test predicts mortality in a pulmonary nontuberculous mycobacteria-predominant bronchiectasis cohort.

Authors:  Rebekah A Blakney; Emily E Ricotta; Dean Follmann; Jessica Drew; Kelly A Carey; Lisa N Glass; Chevalia Robinson; Sandra MacDonald; Pamela J McShane; Kenneth N Olivier; Kevin Fennelly; D Rebecca Prevots
Journal:  BMC Infect Dis       Date:  2022-01-21       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.